- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04623008
Using Mental Imagination to Prevent Excessive Gestational Weight Gain in Overweight and Obese Pregnant Women (MAWI)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ohio
-
Columbus, Ohio, United States, 43210
- The Ohio State University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Participants must be pregnant women ≤ 13 week-gestation with a single fetus as assessed by ultrasound.
- Participants must also have self-reported pre-pregnancy body mass index (BMI) of 25.0-45.0 kg/m2 and height (height and weight to compute body mass index).
- Ability to read and speak English,
- Age of 18-45 years,
- Access to a working smart phone with unlimited text messaging,
- Access to internet,
- Receipt of prenatal care from our collaborating clinics and plan to deliver the baby at The Ohio State University (OSU) Wexner Medical Center,
- Resident of Franklin Count,
- Committed to the 20-week intervention.
Exclusion Criteria:
- Self-reported history of ≥ 3 miscarriages,
- Planned termination of the pregnancy,
- Diagnosed hypertension and/or type 1 or 2 diabetes,
- History of or current diagnosis of an eating disorder,
- Serious current physical disease (e.g., renal disease or cancer),
- Past bariatric surgery,
- Current or history of substance abuse in the past 6 months,
- Current treatment for a serious psychological disorder (e.g., schizophrenia and bipolar disorder),
- Contraindications to walking,
- Consented women will become not eligible to participate in the study if they are not randomized by 16-week 6 days gestation. This is because the study intervention starts ≤ 17 weeks gestation.
- Women will become not ineligible for participation if they did not complete the baseline data.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Goal-Oriented Episodic Future Thinking (GOEFT) Intervention
In addition to usual prenatal care, intervention participants will receive a 20-week intervention via web and individual health counseling.
The intervention topics focus on stress management, healthy eating, and physical activity.
|
Individuals in the intervention group will receive a 20-week web-based intervention and individual health coaching focused on stress management, healthy eating and physical activity.
|
|
No Intervention: Usual Prenatal Care
The usual prenatal care group will receive usual care from their providers
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percent Change in Body Weight
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
|
Data extracted from electronic medical record
|
Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
|
|
Percent Change in Body Weight
Time Frame: 24-27 week-gestation (T2) to 35-37 week-gestation (T3)
|
Data extracted from electronic medical record
|
24-27 week-gestation (T2) to 35-37 week-gestation (T3)
|
|
Percent Change in Body Weight
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
|
Data extracted from electronic medical record
|
Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Autonomous Motivation for Stress Management
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
|
Will be measured using Treatment Self-Regulation Questionnaire (6 items) to measure autonomous motivation for stress management (6 items) Values are: 1 - Not At All True, 2, 3, 4 - Somewhat True, 5, 6, 7 - Very True The investigators will sum 6 items to create a composite score, ranging from 6 to 42. Higher scores indicate higher autonomous motivation for stress management. |
Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
|
|
Change in Autonomous Motivation for Healthy Eating
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
|
Will be measured using Treatment Self-Regulation Questionnaire (6 items) to measure autonomous motivation for Healthy Eating (6 items) Values are: 1 - Not At All True, 2, 3, 4 - Somewhat True, 5, 6, 7 - Very True The investigators will sum 6 items to create a composite score, ranging from 6 to 42. Higher scores indicate higher autonomous motivation for Healthy Eating. |
Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
|
|
Change in Autonomous Motivation for Physical Activity
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
|
Will be measured using Treatment Self-Regulation Questionnaire (6 items) to measure autonomous motivation for Physical Activity (6 items) Values are: 1 - Not At All True, 2, 3, 4 - Somewhat True, 5, 6, 7 - Very True The investigators will sum 6 items to create a composite score, ranging from 6 to 42. Higher scores indicate higher autonomous motivation for Physical Activity. |
Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
|
|
Change in Autonomous Motivation for Stress Management
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
|
Will be measured using Treatment Self-Regulation Questionnaire (6 items) to measure autonomous motivation for stress management (6 items) Values are: 1 - Not At AllTrue, 2, 3, 4 - Somewhat True, 5, 6, 7 - Very True The investigators will sum 6 items to create a composite score, ranging from 6 to 42. Higher scores indicate higher autonomous motivation for stress managment. |
Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
|
|
Change in Autonomous Motivation for Healthy Eating
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
|
Will be measured using Treatment Self-Regulation Questionnaire (6 items) to measure autonomous motivation for Healthy Eating (6 items) Values are: 1 - Not At All True, 2, 3, 4 - Somewhat True, 5, 6, 7 - Very True The investigators will sum 6 items to create a composite score, ranging from 6 to 42. Higher scores indicate higher autonomous motivation for Healthy Eating |
Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
|
|
Change in Autonomous Motivation for Physical Activity
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
|
Will be measured using Treatment Self-Regulation Questionnaire (6 items) to measure autonomous motivation for Physical Activity (6 items) Values are: 1 - Not At All True, 2, 3, 4 - Somewhat True, 5, 6, 7 - Very True The investigators will sum 6 items to create a composite score, ranging from 6 to 42. Higher scores indicate higher autonomous motivation for Physical Activity. |
Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
|
|
Change in Coping Self-efficacy
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
|
Will be measured using a "Survey for Coping Self-efficacy" (10 items) Values are: 1 - Not At All Confident, 2 - Not Too Confident, 3 - Somewhat Confident, 4 - Very Confident The investigators will sum 10 items to create a composite score, ranging from 10 to 40. Higher scores indicate higher coping self-efficacy. |
Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
|
|
Change in Coping Self-efficacy
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
|
Will be measured using a "Survey for Coping Self-efficacy" (10 items) Values are: 1 - Not At All Confident, 2 - Not Too Confident, 3 - Somewhat Confident, 4 - Very Confident The investigators will sum 10 items to create a composite score, ranging from 10 to 40. Higher scores indicate higher coping self-efficacy. |
Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
|
|
Change in Healthy Eating Self-efficacy
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
|
Will be measured using a "Survey for Healthy Eating Self-efficacy" (8 items) Values are: 1 - Not At All Confident, 2 - Not Too Confident, 3 - Somewhat Confident, 4 - Very Confident. The investigators will sum all 8 items to create a composite score, ranging from 8 to 32. The higher score, the higher healthy eating self-efficacy. |
Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
|
|
Change in Healthy Eating Self-efficacy
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
|
Will be measured using a "Survey for Healthy Eating Self-efficacy" (8 items) Values are: 1 - Not At All Confident, 2 - Not Too Confident, 3 - Somewhat Confident, 4 - Very Confident The investigators will sum all 8 items to create a composite score, ranging from 8 to 32. The higher score, the higher healthy eating self-efficacy. |
Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
|
|
Change in Physical Activity Self-efficacy
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
|
Will be measured using a "Survey for Physical Activity Self-efficacy" (10 items) that ask participants' confidence in performing the specific activity. Values are: 1 - Not At All Confident, 2 - Not Too Confident, 3 - Somewhat Confident, 4 - Very Confident The investigators will sum all 10 items to create a composite score, ranging from 10 to 40. The higher score, the higher physical activity self-efficacy. |
Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
|
|
Change in Physical Activity Self-efficacy
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
|
Will be measured using a "Survey for Physical Activity Self-efficacy" (10 items) that ask participants' confidence in performing the specific activity. Values are: 1 - Not At All Confident, 2 - Not Too Confident, 3 - Somewhat Confident, 4 - Very Confident The investigators will sum all 10 items to create a composite score, ranging from 10 to 40. The higher score, the higher physical activity self-efficacy. |
Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
|
|
Change in Perceived Stress
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
|
Will be measured using The Perceived Stress Scale (10 items) that measures the degree to which situations in one's life are appraised as stressful. Values are: 0 - Never, 1 - Almost Never, 2 - Sometimes, 3 - Fairly Often, 4 - Very Often The investigators will sum 10 items to create a composite score, ranging from 0 to 40. The higher score, the higher levels of perceived stress. |
Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
|
|
Change in Perceived Stress
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
|
Will be measured using The Perceived Stress Scale (10 items) that measures the degree to which situations in one's life are appraised as stressful. Values are: 0 - Never, 1 - Almost Never, 2 - Sometimes, 3 - Fairly Often, 4 - Very Often The investigators will sum 10 items to create a composite score, ranging from 0 to 40. The higher score, the higher levels of perceived stress. |
Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
|
|
Percentage of Participants Diagnosed With Gestational Diabetes
Time Frame: 24-27 week-gestation (T2) to 35-37 week-gestation (T3)
|
Data extracted from electronic medical record.
Percentage of participants who were diagnosed with Gestational Diabetes during the study timeframe.
|
24-27 week-gestation (T2) to 35-37 week-gestation (T3)
|
|
Percentage of Participants Diagnosed With Gestational Hypertension
Time Frame: 24-27 week-gestation (T2) to 35-37 week-gestation (T3)
|
Data extracted from electronic medical record.
Percentage of participants diagnosed with Gestational Hypertension in the study timeframe.
|
24-27 week-gestation (T2) to 35-37 week-gestation (T3)
|
|
Percentage of Participants With Cesarean Delivery
Time Frame: 35-37 week-gestation (T3)
|
Data extracted from electronic medical record.
Percentage of participants who experienced Cesarean Delivery.
|
35-37 week-gestation (T3)
|
|
Newborn Body Weight
Time Frame: 35-37 week-gestation (T3)
|
Data extracted from electronic medical record.
Newborn Body Weight taken at birth.
|
35-37 week-gestation (T3)
|
|
Percentage of Participants With Premature (<37 Weeks Gestation) Births
Time Frame: 35-37 week-gestation (T3)
|
Gestational age for each participant was extracted from electronic medical record and births before 37 weeks gestation were considered to be premature.
The number of premature births was averaged within the study groups.
|
35-37 week-gestation (T3)
|
|
Percentage of Change in Dietary Intake Behaviors - Caloric Intake (Kcal)
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
|
Assessed using the National Cancer Institute Automated Self-Administered 24-hour Recall (ASA24). Participants completed 24-hour Dietary Recalls on two random days over a week. The variable of interest - calories (Kcal) - values for the 2 24-hour periods were added to ascertain the total amount consumed at the specific data collection time periods. Data from Baseline (T1) was compared to that collected at T2 for each participant and averaged for an aggregate score. Positive numbers represent an increase in calories consumed, negative numbers represent a decrease in calories consumed. Only participants who completed 2 days worth of dietary data were included in this analysis. |
Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
|
|
Percentage of Change in Dietary Intake Behaviors - Fat (gm)
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
|
Assessed using the National Cancer Institute Automated Self-Administered 24-hour Recall (ASA24). Participants completed 24-hour Dietary Recalls on two random days over a week. The variable of interest - fat (gm) - values for the 2 24-hour periods were added to ascertain the total amount consumed at the specific data collection time periods. Data from Baseline (T1) was compared to that collected at T2 for each participant and averaged for an aggregate score. Positive numbers represent an increase in fat consumed, negative numbers represent a decrease in fat consumed. Only participants who completed 2 days worth of dietary data were included in this analysis. |
Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
|
|
Percentage of Change in Dietary Intake Behaviors - Fruit (Cup)
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
|
Assessed using the National Cancer Institute Automated Self-Administered 24-hour Recall (ASA24). Participants completed 24-hour Dietary Recalls on two random days over a week. The variable of interest - fruit (cup) - values for the 2 24-hour periods were added to ascertain the total amount consumed at the specific data collection time periods. Data from Baseline (T1) was compared to that collected at T2 for each participant and averaged for an aggregate score. Positive numbers represent an increase in fruit consumed, negative numbers represent a decrease in fruit consumed. Only participants who completed 2 days worth of dietary data were included in this analysis. |
Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
|
|
Percentage of Change in Dietary Intake Behaviors - Vegetable (Cup)
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
|
Assessed using the National Cancer Institute Automated Self-Administered 24-hour Recall (ASA24). Participants completed 24-hour Dietary Recalls on two random days over a week. The variable of interest - vegetables (cup) - values for the 2 24-hour periods were added to ascertain the total amount consumed at the specific data collection time periods. Data from Baseline (T1) was compared to that collected at T2 for each participant and averaged for an aggregate score. Positive numbers represent an increase in vegetables consumed, negative numbers represent a decrease in vegetables consumed. Only participants who completed 2 days worth of dietary data were included in this analysis. |
Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
|
|
Percentage of Change in Dietary Intake Behaviors - Added Sugars (Teaspoon or 4gm)
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
|
Assessed using the National Cancer Institute Automated Self-Administered 24-hour Recall (ASA24). Participants completed 24-hour Dietary Recalls on two random days over a week. The variable of interest - added sugars teaspoon or 4 gm) - values for the 2 24-hour periods were added to ascertain the total amount consumed at the specific data collection time periods. Data from Baseline (T1) was compared to that collected at T2 for each participant and averaged for an aggregate score. Positive numbers represent an increase in added sugars consumed, negative numbers represent a decrease in added sugars consumed. Only participants who completed 2 days worth of dietary data were included in this analysis. |
Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
|
|
Percentage of Change in Dietary Intake Behaviors - Caloric Intake (Kcal)
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
|
Assessed using the National Cancer Institute Automated Self-Administered 24-hour Recall (ASA24). Participants completed 24-hour Dietary Recalls on two random days over a week. The variable of interest - calories (Kcal) - values for the 2 24-hour periods were added to ascertain the total amount consumed at the specific data collection time periods. Data from Baseline (T1) was compared to that collected at T3 for each participant and averaged for an aggregate score. Positive numbers represent an increase in calories consumed, negative numbers represent a decrease in calories consumed. Only participants who completed 2 days worth of dietary data were included in this analysis. |
Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
|
|
Percentage of Change in Dietary Intake Behaviors - Fat Intake (gm)
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
|
Assessed using the National Cancer Institute Automated Self-Administered 24-hour Recall (ASA24). Participants completed 24-hour Dietary Recalls on two random days over a week. The variable of interest - fat (gm) - values for the 2 24-hour periods were added to ascertain the total amount consumed at the specific data collection time periods. Data from Baseline (T1) was compared to that collected at T3 for each participant and averaged for an aggregate score. Positive numbers represent an increase in fat consumed, negative numbers represent a decrease in fat consumed. Only participants who completed 2 days worth of dietary data were included in this analysis. |
Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
|
|
Percentage of Change in Dietary Intake Behaviors - Fruit Intake (Cups)
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
|
Assessed using the National Cancer Institute Automated Self-Administered 24-hour Recall (ASA24). Participants completed 24-hour Dietary Recalls on two random days over a week. The variable of interest - fruit (cup) - values for the 2 24-hour periods were added to ascertain the total amount consumed at the specific data collection time periods. Data from Baseline (T1) was compared to that collected at T3 for each participant and averaged for an aggregate score. Positive numbers represent an increase in fruit consumed, negative numbers represent a decrease in fruit consumed. Only participants who completed 2 days worth of dietary data were included in this analysis. |
Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
|
|
Percentage of Change in Dietary Intake Behaviors - Vegetable Intake (Cups)
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
|
Assessed using the National Cancer Institute Automated Self-Administered 24-hour Recall (ASA24). Participants completed 24-hour Dietary Recalls on two random days over a week. The variable of interest - vegetable (cup) - values for the 2 24-hour periods were added to ascertain the total amount consumed at the specific data collection time periods. Data from Baseline (T1) was compared to that collected at T3 for each participant and averaged for an aggregate score. Positive numbers represent an increase in vegetables consumed, negative numbers represent a decrease in vegetables consumed. Only participants who completed 2 days worth of dietary data were included in this analysis. |
Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
|
|
Percentage of Change in Dietary Intake Behaviors - Added Sugars Intake (gm)
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
|
Assessed using the National Cancer Institute Automated Self-Administered 24-hour Recall (ASA24). Participants completed 24-hour Dietary Recalls on two random days over a week. The variable of interest - added sugars (teaspoon or 4 gm) - values for the 2 24-hour periods were added to ascertain the total amount consumed at the specific data collection time periods. Data from Baseline (T1) was compared to that collected at T3 for each participant and averaged for an aggregate score. Positive numbers represent an increase in added sugars consumed, negative numbers represent a decrease in added sugars consumed. Only participants who completed 2 days worth of dietary data were included in this analysis. |
Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
|
|
Percentage of Change in Physical Activity - 7-Day Metabolic Equivalent of Task (MET)
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
|
Assessed using Actigraph (GT3x), an objective measurement of physical activity. Investigators distributed the Actigraph in person participants' home (T2 and T3) to wear at the wrist at least seven consecutive days (≥ 10 hours/per day). The variable of interest - 7-day MET - values for the period was added to ascertain the total amount at the specific data collection time periods. Data from Baseline (T1) was compared to that collected at T2 for each participant and averaged for an aggregate score. Positive numbers represent an increase in physical activity negative numbers represent a decrease in physical. Only participants who completed the minimum requirement for reporting [wear at the wrist at least seven consecutive days (≥ 10 hours/per day)] were included in the analysis. |
Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
|
|
Percentage of Change in Physical Activity - 7-Day Metabolic Equivalent of Task (MET)
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
|
Assessed using Actigraph (GT3x), an objective measurement of physical activity. Investigators distributed the Actigraph in person participants' home (T2 and T3) to wear at the wrist at least seven consecutive days (≥ 10 hours/per day). The variable of interest - 7-day MET - values for the period was added to ascertain the total amount at the specific data collection time periods. Data from Baseline (T1) was compared to that collected at T3 for each participant and averaged for an aggregate score. Positive numbers represent an increase in physical activity negative numbers represent a decrease in physical. Only participants who completed the minimum requirement for reporting [wear at the wr |
Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
|
|
Change in Emotion Regulation
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
|
The Emotion Regulation Questionnaire (10 items) was used to measure emotional control.
The questionnaire asked participants to report the use of emotional regulatory process using a 7-point scale ranging from 1 (strongly disagree) to 7 (strongly agree).
After revise coding 4 items, we summed responses of 10 items to create an emotional control score (ranged from 10 to 70).
Higher scores indicated better emotional control.
|
Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
|
|
Change in Emotion Regulation
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
|
The Emotion Regulation Questionnaire (10 items) was used to measure emotional control.
The questionnaire asked participants to report the use of emotional regulatory process using a 7-point scale ranging from 1 (strongly disagree) to 7 (strongly agree).
After revise coding 4 items, we summed responses of 10 items to create an emotional control score (ranged from 10 to 70).
Higher scores indicated better emotional control.
|
Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
|
|
Change in Executive Function - Behavior Regulation
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
|
The Behavior Rating Inventory of Executive Function-Adults (75 items) was used to measure executive function.
This survey asked participants to rate self-regulation behaviors in the everyday environment using a 3-point Likert scale ranging from 0 (never) to 2 (often).
This survey covers 2 main domains: behavior regulation (30 items) and metacognition (45 items).
We summed responses to the 30 behavior regulation items to create a behavior regulation score.
Behavior regulation scores range from 0-60.
We used the same approach to create a composite score for metacognition.
Higher scores indicated worse behavior regulation or metacognition.
The scores from T1 were compared to scores for T2 to evaluate the effect of the intervention.
|
Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
|
|
Change in Executive Function - Behavioral Regulation
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
|
The Behavior Rating Inventory of Executive Function-Adults (75 items) was used to measure executive function.
This survey asked participants to rate self-regulation behaviors in the everyday environment using a 3-point Likert scale ranging from 0 (never) to 2 (often).
This survey covers 2 main domains: behavior regulation (30 items) and metacognition (45 items).
We summed responses to the 30 behavior regulation items to create a behavior regulation score.
Behavior regulation scores range from 0-60.
We used the same approach to create a composite score for metacognition.
Higher scores indicated worse behavior regulation or metacognition.
The scores from T1 were compared to scores for T3 to evaluate the effect of the intervention.
|
Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
|
|
Change in Executive Function - Metacognition
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
|
The Behavior Rating Inventory of Executive Function-Adults (75 items) was used to measure executive function [31].
This survey asked participants to rate self-regulation behaviors in the everyday environment using a 3-point scale ranging from 0 (never) to 2 (often).
This survey covers 2 main domains: behavior regulation (30 items) and metacognition (45 items).
We summed responses to the 30 behavior regulation items to create a behavior regulation score.
We used the same approach to create a composite score for metacognition.
Metacognition scores range from 0-90.
Higher scores indicated worse metacognition.
The scores from T1 were compared to scores from T2 to evaluate the effect of the intervention.
|
Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
|
|
Change in Executive Function - Metacognition
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
|
The Behavior Rating Inventory of Executive Function-Adults (75 items) was used to measure executive function [31].
This survey asked participants to rate self-regulation behaviors in the everyday environment using a 3-point scale ranging from 0 (never) to 2 (often).
This survey covers 2 main domains: behavior regulation (30 items) and metacognition (45 items).
We summed responses to the 30 behavior regulation items to create a behavior regulation score.
We used the same approach to create a composite score for metacognition.
Metacognition scores range from 0-90.
Higher scores indicated worse metacognition.
The scores from T1 were compared to scores from T3 to evaluate the effect of the intervention.
|
Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Mei-Wei Chang, PhD, Ohio State University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2019H0441
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
Clinical Trials on Goal-Oriented Episodic Future Thinking
-
Ohio State UniversityCompleted
-
University of VermontWithdrawnTobacco Smoking
-
Virginia Polytechnic Institute and State UniversityNational Cancer Institute (NCI); Roswell Park Comprehensive Cancer CenterNot yet recruitingCigarette Smoking BehaviorUnited States
-
Henry Ford Health SystemMichigan State University; University of Kansas; University of Maryland, College...Recruiting
-
Virginia Polytechnic Institute and State UniversityNational Institute of Nursing Research (NINR); Carilion Clinic; University at...CompletedType 2 DiabetesUnited States
-
Henry Ford Health SystemUniversity of Kansas; University of Maryland, College ParkCompletedBehavioral HealthUnited States
-
Henry Ford Health SystemMichigan State University; University of Kansas; University of Maryland, College...CompletedBehavioral HealthUnited States
-
Virginia Polytechnic Institute and State UniversityCarilion ClinicCompletedHormone Receptor Positive Malignant Neoplasm of BreastUnited States
-
State University of New York at BuffaloEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompleted
-
Henry Ford Health SystemUniversity of Kansas; University of Maryland, College ParkActive, not recruiting